Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy
Vivek P. Chavda, Guanghong Luo, Rajashri Bezbaruah, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 16
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
Vivek P. Chavda, Vrashabh V. Sugandhi, Chandrakantsing V. Pardeshi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 85, pp. 104579-104579
Open Access | Times Cited: 22
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 7
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 6
RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 11
SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: a rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with Spike protein (S)-based vaccines
Yoel Esteve-Sánchez, Andy Hernández‐Montoto, María Ángeles Tormo‐Más, et al.
Sensors and Actuators B Chemical (2024) Vol. 419, pp. 136378-136378
Open Access | Times Cited: 3
Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations and Applications
Teenu Sharma, M. Arockia Babu, Atul Jain, et al.
Nanoscience & Nanotechnology-Asia (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 2
History of vaccination
Vivek P. Chavda, Pankti C. Balar, Vasso Apostolopoulos
Elsevier eBooks (2024), pp. 1-12
Closed Access | Times Cited: 1
Personalized vaccines, novel vaccination technologies, and future prospects
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 225-242
Closed Access | Times Cited: 1
The development and technologies of RNA therapeutics
Huong Lan Vuong, Chu Thanh Lan, Hien Thi Thu Le
Progress in molecular biology and translational science (2024), pp. 13-39
Closed Access
The breakthrough in vaccination: Nobel Prize in Physiology or Medicine 2023
Krisztina Hagymási
Structural Chemistry (2024) Vol. 35, Iss. 2, pp. 695-699
Open Access
Nanoparticle‐Based mRNA Vaccines
Lakshmi Vineela Nalla, Siva Nageswara Rao Gajula, Vivek P. Chavda
(2024), pp. 275-303
Closed Access
Nanoparticle Properties
Kajal Baviskar, Brijesh Shah, Anjali Bedse, et al.
(2024), pp. 153-191
Closed Access
Nanotechnology and Vaccine Development
Keshava Jetha, Praful D. Bharadia, Manish P. Patel
(2024), pp. 63-93
Closed Access
Editorial: Nucleic acid-based therapies for cardiovascular diseases
Fabio Martelli, Paras K. Mishra, Andrea Caporali
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Expression system and purification process for the vaccine production
Suneetha Vuppu, Toshika Mishra, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 131-151
Closed Access
Vector-based vaccine delivery and associated immunity
Mohsen Akbarian, Lobat Tayebi, Elrashdy M. Redwan, et al.
Elsevier eBooks (2024), pp. 73-98
Closed Access
Nanoparticle-based vaccines and future vaccine technologies
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access
Antiviral Activity of Physta®, Standardised Water Extract of Eurycoma longifolia against SARS-CoV-2: An in vitro Study
Sasikala M. Chinnappan, A George, Pouya Hassandarvish, et al.
Malaysian Journal of Pharmaceutical Sciences (2024) Vol. 22, Iss. 1, pp. 77-86
Open Access
Nanoparticle-Mediated Mucosal Vaccination: Harnessing Nucleic Acids for Immune Enhancement
Wajid Hussain, Sadia Chaman, Hafiza Nazia Koser, et al.
Current Microbiology (2024) Vol. 81, Iss. 9
Closed Access
Modern Biomedical Technologies versus Emerging Pathogenic Microbes: Insights into the Confronting Situation
Lalit Umesh, Sanish Verma
Science Insights (2024) Vol. 45, Iss. 2, pp. 1475-1481
Open Access
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access
Scrutinizing the COVID-19 vaccine safety debate
Khalid A. Bin Abdulrahman, Amro K. Bin Abdulrahman
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
COVID-19 story: Entry and immune response
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas (2024)
Closed Access
Page 1 - Next Page

Scroll to top